FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa
- 5 January 2004
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 314 (2), 409-414
- https://doi.org/10.1016/j.bbrc.2003.12.102
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Human recombinant endopeptidase PHEX has a strict S1' specificity for acidic residues and cleaves peptides derived from fibroblast growth factor-23 and matrix extracellular phosphoglycoproteinBiochemical Journal, 2003
- Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked HypophosphatemiaNew England Journal of Medicine, 2003
- Vitamin D and autoimmune diabetesJournal of Cellular Biochemistry, 2003
- In Vitro and In Vivo Analysis of the Immune System of Vitamin D Receptor Knockout MiceJournal of Bone and Mineral Research, 2001
- Identification of a Novel Fibroblast Growth Factor, FGF-23, Preferentially Expressed in the Ventrolateral Thalamic Nucleus of the BrainBiochemical and Biophysical Research Communications, 2000
- PHEX gene and hypophosphatemiaKidney International, 2000
- Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaningNature Genetics, 1997
- Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice.JCI Insight, 1997
- A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic ricketsNature Genetics, 1995
- Efficient selection for high-expression transfectants with a novel eukaryotic vectorGene, 1991